Fund managers in India are launching more pharmaceutical sectoral funds to cash in on the explosive potential of generic drug exports and investor demand for stocks not exposed to government policy shifts. The drugs sector, dominated by privately run companies, is seen as largely insulated from domestic political swings that can affect other sectors, where state-run companies abound or are susceptible to changes of government and policy.
